Division of Genetic Medicine and Clinical Pharmacology Archive — Page 9 of 12

Vanderbilt Center for Tourette Syndrome and Other Tic Disorders team members include, from left, Angela White, RN, Mariana Ciobanu, MD, KellyAnn Primm, OTR/L, David Isaacs, MD, MPH, Heather Riordan, MD, Michelle Eckland, Jessica Stroh, RN, and Kayla Johnson, PharmD.
February 23, 2022

VUMC designated a Tourette syndrome center of excellence

The Vanderbilt Center for Tourette Syndrome and Other Tic Disorders has been designated a Tourette Association of America (TAA) Center of Excellence.

December 2, 2021

Gene discoveries give new hope to people who stutter

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.

December 2, 2021

Study links depression scores, white blood cell count

(iStock)
November 30, 2021

Study examines genetic risk for suicide attempt

New research from Vanderbilt identifies the first replicated genomic region contributing to risk of suicide attempt and confirms that genetic risk for the trait is not driven solely by risk for psychiatric disorders.

November 18, 2021

Seven from VUMC among most highly cited researchers

Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

October 21, 2021

Study links genetic variants, protein expression and human diseases

An international research team has developed a new resource that connects genetic variants and protein expression, which is expected to speed the identification of genes that cause disease — and point to novel treatment strategies.